Patent ID: 7309700
Filing Date: 2007-12-18
Classification: A61P,C07D

Abstract:
1. The crystalline form of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2′,3′-e] [1,4]diazepin-6-one dihydrate having an X-ray powder diffraction pattern that comprises peaks at 23.4, 24.9, 17.3, 24.3, 12.1, 18.5 and 17.6 degrees 2θ (±0.2 degrees 2θ) and wherein said X-ray powder diffraction pattern is made using CuK α radiation.